2359.HK · HKG · Healthcare
WuXi AppTec Co., Ltd.
Also onConsensus Drift
Implied value per share
HKD 98.01
Market price
HKD 200.00
Implied upside
-51.0%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · CNY model at 1.1708
Current EV/EBITDA of 28.0x sits outside a defensible 3-20x band, so the exit multiple is capped at 20.0x. A multiple that far out usually means EBITDA is the wrong denominator for this business.
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (CNY). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | CNY 47.7bn | CNY 50.0bn | CNY 52.5bn | CNY 55.1bn | CNY 57.8bn | +4.9% |
| EBIT | CNY 14.4bn | CNY 15.1bn | CNY 15.9bn | CNY 16.7bn | CNY 17.5bn | +4.9% |
| NOPAT | CNY 12.0bn | CNY 12.6bn | CNY 13.3bn | CNY 13.9bn | CNY 14.6bn | +4.9% |
| Add depreciation & amortisation | CNY 2.9bn | CNY 3.1bn | CNY 3.2bn | CNY 3.4bn | CNY 3.6bn | +4.9% |
| Less capital expenditure | CNY -7.3bn | CNY -7.7bn | CNY -8.1bn | CNY -8.5bn | CNY -8.9bn | +4.9% |
| Less increase in working capital | CNY 290.2m | CNY 304.4m | CNY 319.4m | CNY 335.2m | CNY 351.6m | -4.9% |
| Free cashflow to firm | CNY 8.0bn | CNY 8.3bn | CNY 8.8bn | CNY 9.2bn | CNY 9.6bn | +4.9% |
| Discount factor | 0.9633 | 0.8940 | 0.8296 | 0.7699 | 0.7145 | - |
| Present value | CNY 7.7bn | CNY 7.5bn | CNY 7.3bn | CNY 7.1bn | CNY 6.9bn | -2.6% |
| Present Value Of The Forecast | CNY 36.4bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 3.20% | HKD assumption - no free live source available for this market (assumption) |
| Equity risk premium | 7.00% | Market assumption |
| Beta | 0.659 | Reported 0.491, pulled toward 1.0 (Blume) |
| Cost of equity | 7.81% | Risk-free + beta x equity risk premium |
| Cost of debt | 4.56% | Interest expense / average total debt |
| Market capitalisation | CNY 606.4bn | 98.6% of capital |
| Total debt | CNY 8.4bn | 1.4% of capital, book value as a proxy |
| Tax rate | 16.5% | Effective, capped at statutory |
| WACC | 7.76% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
83% of EV
- Forecast FCFF, final year
- CNY 9.6bn
- Capex at depreciation, working capital in reinvestment
- CNY 14.8bn
- Less reinvestment at g/ROIC (15.6% of NOPAT)
- CNY -2.3bn
- Capitalised
- CNY 12.5bn
- ROIC (reported)
- 16.1%
- Terminal value, undiscounted
- CNY 243.1bn
- Terminal value, discounted
- CNY 173.7bn
- Enterprise value
- CNY 210.0bn
- Less net debt
- CNY -32.5bn
- Equity value
- CNY 242.5bn
Exit at 20.0x EBITDA
89% of EV
- Terminal value, undiscounted
- CNY 420.9bn
- Terminal value, discounted
- CNY 300.7bn
- Enterprise value
- CNY 337.1bn
- Less net debt
- CNY -32.5bn
- Equity value
- CNY 369.6bn
Spread between methods: 42%.
Sensitivity
Value per share (CNY) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 5.76% | 110.00 | 118.52 | 129.62 | 144.69 | 166.40 |
| 6.76% | 90.53 | 95.34 | 101.26 | 108.71 | 118.42 |
| 7.76% | 77.33 | 80.25 | 83.72 | 87.88 | 93.00 |
| 8.76% | 67.79 | 69.66 | 71.81 | 74.31 | 77.27 |
| 9.76% | 60.58 | 61.82 | 63.20 | 64.78 | 66.59 |
Outlined: this model. Green text: above today's price of 170.82. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 4.9% | 23.7% | +18.7pp |
| EBIT margin | 30.2% | 63.9% | +33.7pp |
| Discount rate | 7.8% | 4.9% | -2.8pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.